- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0025116

About Invision Medi Sciences Private Limited
Data last updated:
Invision Medi Sciences Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24234KA2011PTC057213. Its GSTIN is 29AACCI5517M1Z7 (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Mukeshkumar (Managing Director) and Nataraj Nanjundappa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bengaluru, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.08 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹60.28 Lakh (net margin 3.3%) and EBITDA of ₹1.99 Cr (EBITDA margin 11%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 2% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Invision Medi Sciences and Intencis Derma Care. As per MCA filings, the company has open charges of ₹4.7 Cr and satisfied charges of ₹2.94 Cr on record. Court records list 10 cases involving the company, including 4 filed by the company and 6 filed against it; 2 cases are pending.
Invision Medi Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0025116). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website invisionmedi.com.
Company details
Recognitions & Rankings of Invision Medi Sciences
Contact details
Invision Medi Sciences Private Limited's registered office is in Bengaluru, Karnataka. Its website is invisionmedi.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3rd Floor No. 194/31/2/74 – 75 Begur Sub Zone Behind Metro Wholesale Beretena Agrahar, A, Bengaluru, Karnataka, India – 560100
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Invision Medi Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Invision Medi Sciences operates two associated brands: Invision Medi Sciences and Intencis Derma Care. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical drugs for cardiac, diabetic, and other health needs. | invisionmedi.com | |
| Provides healthcare solutions focused on dermatology and skin care. | intenciscare.com |
Business activity
The main business activity of Invision Medi Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Invision Medi Sciences Private Limited, buy the company report.
Financials of Invision Medi Sciences Private Limited
FY 2025 filings availableInvision Medi Sciences Private Limited reported revenue of ₹18.08 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹18.08 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.99 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹60.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Invision Medi Sciences Private Limited, buy the company report.
Board of directors of Invision Medi Sciences Private Limited
Invision Medi Sciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nataraj Nanjundappa Also directs: Invision Pharma Limited | Director | 12 Oct 2013 | 13 Years 1 Months | Current |
| Mukeshkumar Also directs: Minova Life Sciences Private Limited, Invision Pharma Limited | Managing Director | 22 Feb 2011 | 15 Years 8 Months | Current |
| Chirag Mukeshkumar Also directs: Minova Life Sciences Private Limited, Invision Pharma Limited | Director | 04 Apr 2016 | 10 Years 7 Months | Current |
| Seema Also directs: Minova Life Sciences Private Limited | Director | 04 Nov 2024 | 2 Years 0 Months | Current |
Peer comparison
Invision Medi Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Invision Medi Sciences Private Limitedthis company | ₹18.08 Cr (FY 2025) | ₹60.28 Lakh | 3.3% | 6.0% | 14 | Bengaluru, Karnataka, India |
| Zenta Healthcare Private Limited | ₹17.21 Cr (FY 2025) | 29.0% | New Delhi, Delhi, India | |||
| Nilsan Pharmaceuticals Private Limited | ₹17.12 Cr (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Glee Biotech Limited | ₹17.11 Cr (FY 2024) | -7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Invision Medi Sciences Private Limited, buy the company report.
Auditor
Invision Medi Sciences Private Limited is audited by PARASMAL KANKARIYA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARASMAL KANKARIYA | FY 2024 | 022221 |
Shareholding
The shareholding of Invision Medi Sciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Invision Medi Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Nov 2024 | 101005191 | Others | ₹4.7 Cr | Open | |
| 19 Feb 2013 | 10404737 | Others | ₹2.94 Cr | Satisfied |
To see the full charge records of Invision Medi Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Invision Medi Sciences Private Limited has 10 court cases on record: 4 filed by Invision Medi Sciences, 6 filed against it. 2 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 2 |
| District courts | 3 | 2 | 0 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Intas Pharmaceuticals Ltd | Disposed |
| Madras High Court | Court case (OP(TM)) | Filed against the company by Aptissen Sa | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against an individual | Pending |
| District court, Kancheepuram, Tamil Nadu | Criminal complaint | Filed against the company by an individual | Disposed |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against an individual | Disposed |
To see the full case history of Invision Medi Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Invision Medi Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Invision Medi Sciences Private Limited has a workforce of 14 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 14 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Invision Medi Sciences Private Limited, buy the company report.
GST
Invision Medi Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCI5517M1Z7 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Invision Medi Sciences Private Limited, buy the company report.
Recent activity
Invision Medi Sciences Private Limited has 4 board changes on record since 2011: 4 appointments. The latest: Seema was appointed as Director on 04 Nov 2024.
Frequently asked questions
Invision Medi Sciences is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2011 (15+ years old) and is registered under CIN U24234KA2011PTC057213.
Invision Medi Sciences has 4 current directors:
- Mukeshkumar - Managing Director
- Nataraj Nanjundappa - Director
- Chirag Mukeshkumar - Director
- Seema - Director
The latest financial statements of Invision Medi Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Invision Medi Sciences is 29AACCI5517M1Z7, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Invision Medi Sciences is U24234KA2011PTC057213. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Invision Medi Sciences has 10 court cases on record: 4 filed by the company and 6 filed against it. 2 are pending. Most are in the high courts.
Invision Medi Sciences was incorporated on 22 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Invision Medi Sciences by revenue are Zenta Healthcare Private Limited, Nilsan Pharmaceuticals Private Limited, Glee Biotech Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Seema was appointed as Director on 04 Nov 2024. Chirag Mukeshkumar was appointed as Director on 04 Apr 2016. Nataraj Nanjundappa was appointed as Director on 12 Oct 2013. Invision Medi Sciences has 4 board changes on record in total.
Yes, Invision Medi Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0025116).
Invision Medi Sciences can be reached through the website invisionmedi.com. Its registered office is in Bengaluru, Karnataka, India.

